# FDA 483 - Kazutomo Toyofuku - September 19, 2025

Source: https://www.keypedia.com/records/483/kazutomo-toyofuku/4db92e0f-cebc-4a9d-b149-f31cd669c908

> FDA 483 for Kazutomo Toyofuku on September 19, 2025. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Kazutomo Toyofuku
- Inspection Date: 2025-09-19
- Product Type: drugs
- Office Name: Office of Inspections and Investigations
- Summary: An FDA inspection of Kazutomo Toyofuku, M.D. in Shinjuku-ku, Tokyo, Japan, a clinical investigator, revealed a significant deficiency in conducting a foreign clinical study. The study was not performed in accordance with Good Clinical Practices, specifically regarding inadequate justification for revisions made to source records weeks after initial entry. This indicates issues with data integrity and adherence to established research protocols.

## Related Officers

- [Business Analyst/Provider Enrollment Specialist](https://www.keypedia.com/people/lakecha-n-lewis/39b6305d-2a9f-448b-9a14-e412b43c8522)

Company: https://www.keypedia.com/companies/kazutomo-toyofuku/0adcee6f-7cd8-4d2d-9d6e-b3b97be0e7ce

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8